PhRMA Disowns Companies Like Valeant and Turing
CEO of Turing has more on his plate today than ever before, as Martin Shkreli was arrested for securities violations.…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
AMA Adds Twenty Schools to Their Accelerating Change in Medical Education…
With medicine and health care delivery in the United States constantly changing in new and exciting ways, the American…
HHS OIG Modifies Advisory Opinion on Patient Assistance Programs
The Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently released a modification of…
FDA: Review of Advisory Committees 2008-2012, Fewer Meetings and More…
Over the years, we have written about the FDA's Advisory Committees with a special interest on "conflict of interest"…
Update on Risk Evaluation and Mitigation Strategies
For many years, we have written about the authority granted to the FDA from the 1997 Food and Drug Administration Amendments Act…
FDA Pushes Back Release of Generic Drug Safety Label Rules
The United States Food and Drug Administration (FDA) has once again pushed back the release of a final rule allowing…
Senate Aging Committee Hearing on Drug Prices: Faster Generics Approval…
The Senate Special Committee on Aging held a hearing on Wednesday, December 9, 2015, to discuss "Sudden Price Spikes in…
Major Drug Pricing Ballot Initiatives Face 2016 Voters
As many of our readers know, drug prices have been in the news for several months now, with many public figures voicing…
2015 Whistleblower Update
The annual report released by the SEC Office of the Whistleblower for the 2015 fiscal year showed an increase in Foreign…
Concerns Over Valeant Lead to Troubles for Other Companies
With Valeant facing constant criticism about their business model, other pharmaceutical companies following similar…